118th Congress · SENATE BILLBILL

S. 5206 — United States Pharmaceutical Supply Chain Review Act

“A bill to require a report on foreign investment in the pharmaceutical industry of the United States.”

Health

Introduced Sep 25, 2024

Last action Sep 25, 2024

Pipeline · Bill → Law

Step 1

Introduced

Sep 25, 2024

Step 2

Referred

Sep 25, 2024

Banking, Housing, and Urban Affairs

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in Senate

Timeline · 2 actions

Sep 25, 2024

Introduced in Senate

Sep 25, 2024

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.